BEIJING/HONG KONG, Jan 29 (Reuters) - Chinese medical device company Shenzhen Mindray Bio-Medical Electronics 300760.SZ said it planned a 6.65 billion yuan ($927 million) deal to gain control of APT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback